Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2001
05/30/2001EP1102590A1 Use of a nk-1 receptor antagonist for treating or preventing abnormal bone resorption
05/30/2001EP1102589A1 Topical compositions comprising an opioid analgesic and an nmda antagonist
05/30/2001EP1102588A1 Pharmaceutical compositions for the prevention and treatment of central nervous system disorders
05/30/2001EP1102587A2 Vitronectin receptor antagonists
05/30/2001EP1102586A1 Use of ginkgo biloba extracts for preparing a medicine for treating amyotrophic lateral sclerosis
05/30/2001EP1102585A2 USE OF CYCLOPENTABENZOFURAN-DERIVATIVES FOR COMBATING NF-$g(k)B-DEPENDENT DISEASES
05/30/2001EP1102584A2 Antioxidant, antiproliferous composition, comprising a carnitine and a carotenoid
05/30/2001EP1102583A2 Treatment of addiction and addiction-related behavior
05/30/2001EP1102582A2 Inhibitors of type 3 3alpha-hydroxysteroid dehydrogenase
05/30/2001EP1102579A1 Medicinal aerosol formulations
05/30/2001EP1102578A1 A new analgesic, anti-inflammatory and wound healing agent
05/30/2001EP1102546A1 Method for increasing milk production in lactating dairy cattle
05/30/2001EP1102536A1 Microbicidal active substances
05/30/2001EP1102535A2 Compounds and methods
05/30/2001EP1100489A4 Method of altering nutritional components of milk produced by a lactating animal
05/30/2001EP1032265A4 New psoralens for pathogen inactivation
05/30/2001EP0929292B1 Method and composition for rewetting contact lenses and relieving eye dryness
05/30/2001EP0914334B1 Process and intermediates for the synthesis of lhrh antagonists
05/30/2001EP0817610B1 Sterile ophthalmological gel preparation applicable in drops and process for producing it
05/30/2001EP0814759B1 Sunscreen compositions comprising a mixture of titanium and zinc oxide particles, method for preparing the same and use thereof
05/30/2001EP0794184B1 6-methoxy-1h-benzotriazole-5-carboxamide derivatives, process for producing the same, and medicinal composition containing the same
05/30/2001EP0752992B1 IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
05/30/2001EP0750616B1 Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds
05/30/2001EP0743847B1 Hair cosmetic composition
05/30/2001EP0727988B1 Aids prophylactic lubricating composition and devices for its use
05/30/2001EP0689443B1 The use of bisphosphonates in bone surgery
05/30/2001EP0689441B1 Pharmaceutical composition in form of a kit comprising prostaglandin e1
05/30/2001EP0688204B1 Composition and cosmetic method for skin
05/30/2001EP0687176B1 Use of riluzole for treating aids-related neural disorders
05/30/2001EP0672043B1 Novel 4-(3-benzofuranyl)piperidinyl and 4-(3-benzothienyl)piperidinyl derivatives and pharmaceutical compositions containing them
05/30/2001EP0665834B1 Quinolone and acridinone derivatives for the treatment of urinary incontinence
05/30/2001EP0660712B1 Transcutaneous in vivo activation of photosensitive agents in blood
05/30/2001EP0658109B1 Metallo porphyrin compositions
05/30/2001EP0656778B1 Enantiomerically pure beta-d-dioxolane-nucleosides
05/30/2001EP0641320B1 Substituted (s)-3-phenylpiperidine derivatives, their preparation and their use as dopamine autoreceptor antagonists
05/30/2001EP0637306B1 4-imidomethyl-1- [2'-phenyl-2'-oxoethyl]- piperidines as serotonin 5ht 2-antagonists, their preparation and use in therapy
05/30/2001EP0633795B1 Antibacterial coated medical implants
05/30/2001CN1297650A Time and location-driven personalized TV
05/30/2001CN1297532A Identification of chemical active agents for inhibiting 1-desoxy-D-xylulose-5-phosphate biosynthetic pathway in parasites, and said active agents
05/30/2001CN1297462A Sulfonated comb polymers and preparations, especially hair cosmetic preparations based on such sulfonated comb polymers
05/30/2001CN1297459A Method for production of polymers from N-vinyl compounds
05/30/2001CN1297451A Glucocorticoid-selective antiinflammatory agents
05/30/2001CN1297449A Novel 2-heterocyclically substd. dihydropyrimidines
05/30/2001CN1297448A Paroxetine ascorbate
05/30/2001CN1297447A Anti-viral pyrimidine derivs
05/30/2001CN1297442A 5-aminoindeno [1,2-c] pyrazol-4-ones as anti-cancer and anti-proliferative agents
05/30/2001CN1297441A Heterocyclically substd. amides used as calpain inhibitors
05/30/2001CN1297440A Piperidinyl and N-amidinopiperidinyl derivs.
05/30/2001CN1297439A 4-amino-(ethylamino)-oxindole dopamine autoreceptor agonists
05/30/2001CN1297438A Substd. indolinones having inhibiting effect on kinases and cycline/CDK complexes
05/30/2001CN1297437A Substd. 2-oxo-alkanoic acid-[2-(indol-3-yl)-ethyl] amides
05/30/2001CN1297436A Substd. pyrrolidine hydroxamate metalloprotease inhibitors
05/30/2001CN1297435A Method for producing enantiomer-free N-methyl-N-[(1S)-1-phenyl-2-[(3S)-3-hydroxypyrrolidine-1-y1)ethyl]-2, 2-diphenyl acetamide
05/30/2001CN1297432A Substd. amides, their production and their use
05/30/2001CN1297431A Phenylsulfonamide-phenylethylamines useful as dopamine receptors
05/30/2001CN1297359A Ophthalmic composition comprising beta-blocker
05/30/2001CN1297355A Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives
05/30/2001CN1297352A Use of organophosphoric compounds for therapeutic and preventative treatment of infections
05/30/2001CN1297351A Intermittent claudication therapeutic drugs comprising pyrroloazepines
05/30/2001CN1297350A Agents for relieving side effects
05/30/2001CN1297349A Adhesive preparations
05/30/2001CN1297344A Method and compositions for in situ formation of protective and/or medicated film on body tissue
05/30/2001CN1296842A 'Sanjisan' for treating syphilis
05/30/2001CN1296834A Liquid medicine 'Fujieye'
05/30/2001CN1296818A Anti-malignant tumor agent for malignant neoplasm contg. cancer
05/30/2001CN1296817A Exterior-applied liquid medicine for treating acne
05/30/2001CN1296816A Stomach-lavaging agent of sympathin
05/30/2001CN1296815A Eye drops of diclofenac sodium
05/30/2001CN1066456C Oligonucleotides having 2'-ether groups
05/30/2001CN1066455C Secomacrolides from class of erythromycins and process for their preparation
05/30/2001CN1066452C Crystalline cephem acid addition salts and processes for their preparation
05/30/2001CN1066451C Thiazoline deriv. composition and use thereof
05/30/2001CN1066449C Tricyclic oxime ethers, processes for their preparation and pharmaceutical compositions contg. them
05/30/2001CN1066448C Amide derivs.
05/30/2001CN1066447C Imidazo [4,5-c] quinoline amines
05/30/2001CN1066446C 4-amino-3-acylnaphthyridine derivs.
05/30/2001CN1066445C Aroyl-piperidine derivs.
05/30/2001CN1066441C Isooxazolyl phenyl sulfonamide derivs. and use of same in preparing endothelin antagonists
05/30/2001CN1066438C Preparation of beta-methyl carbapenem intermediates
05/30/2001CN1066436C Cyclohexanes and cyclohexenes derivs.
05/30/2001CN1066336C Pharmaceutical composition for treatment of alcohol addiction
05/30/2001CN1066329C Preparation of drug composition
05/30/2001CN1066328C Use of alkatropine for preparing medicine
05/30/2001CA2327026A1 Quinoline derivatives useful for inhibiting farnesyl protein transferase
05/29/2001US6239296 Process for a phenylthiobutyl-isoquinoline and intermediates therefor
05/29/2001US6239291 Pyronin antibacterials, process and novel intermediates thereto
05/29/2001US6239288 Biphenyl hydroxy imino butyric acids and their derivatives for treating arthritis
05/29/2001US6239284 Skin disorders; anticancer agents
05/29/2001US6239283 Bactericides; reacting 4-one-tetrahydrothiopyran
05/29/2001US6239267 Nucleotide sequence of ion channel protein associated with capsaicin; diagnosis and treatment of nervous system disorders, incontinence, stroke; antiischemic agents; antiarthritic/antiinflammatory agents; analgesics
05/29/2001US6239265 Oligonucleotides having chiral phosphorus linkages
05/29/2001US6239259 Multivalent and multispecific antigen-binding protein
05/29/2001US6239256 Isolated muteins of proteins SCP-1, and compositions containing the mutein
05/29/2001US6239182 Applying polystyrene sulfonate topically to non-pregnancy risk humans; preventing gonorrhea, chlamydia, aids, and papilloma virus infection
05/29/2001US6239181 Method for preventing and treating peripheral neurophathy by administering selegiline
05/29/2001US6239180 Transdermal therapeutic device and method with capsaicin and capsaicin analogs
05/29/2001US6239179 N-aminoalkyl-2-anthracenecarboxamides; new dopamine receptor subtype specific ligands
05/29/2001US6239178 Administering n3-(carboxyalkyl)-l-arginine derivative as arginosuccinase inhibitor; reducing arginine blood levels totreat headaches
05/29/2001US6239177 Dissolution medium of crotamiton and n-methyl-2-pyrrolidone
05/29/2001US6239176 Administering to treat blood disorders like anemia; wound healing, anticarcinogenic and antiproliferative agents; genetic disorders